Drug-Eluting Stents for Everyone: Is the Price Worth It?

Arq Bras Cardiol. 2020 Jul;115(1):90-91. doi: 10.36660/abc.20200530. Epub 2020 Aug 7.

[Article in English, Portuguese]

Authors

Marcos Danillo P Oliveira¹, Vanessa Teich², Adriano Caixeta¹

Affiliations

¹ Departamento de Cardiologia Intervencionista, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.
² Departamento de Economia da Saúde, Hospital Israelita Albert Einstein, São Paulo, SP, Brasil.

No abstract available

Publication types

Comment

MeSH terms

Brazil
Coronary Restenosis*
Cost-Benefit Analysis
Drug-Eluting Stents*
Humans
Percutaneous Coronary Intervention*
Public Health